Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

Return to program book search

Session Information

CRS C028 - Dermatologic Drug Safety and Efficacy

Tuition fee and ticket required for admission


Date: Tuesday, March 05

CME Credits: 3.00

Location: Room B114/115

Time: 9:00 AM - 12:00 PM

Director: Jeffrey Phillip Callen, MD, FAAD


  • David R. Bickers, MD, FAAD
  • Lauren C. Hughey, MD, FAAD - Handout
  • Mark Lebwohl, MD, FAAD
  • David J. Margolis, MD, FAAD
  • Cindy Owen, MD, FAAD
  • Misha Rosenbach, MD, FAAD
  • Peter C. M. Van de Kerkhof, MD
  • John Joseph Zone, MD, FAAD - Handout

Learning Objectives:
Following this course, the attendee should be able to:

  • Identify safety issues for systemic therapies routinely used to treat dermatologic disease
  • Describe the efficacy of systemic drugs used to treat dermatologic disease
  • Manage patients while on systemic therapies for dermatologic disease

Systemic drugs are often used to treat patients with skin disease. Inherent with their use are potential toxicities. This session will familiarize the attendee with the indications for use, the selection of the patient who is appropriate for their use, and the monitoring for toxicity that should be carried out for the patient during continued therapy.


  • Callen JP (Guest Editor): Dermatologic Therapy, 25: i–iii. doi: 10.1111/j.1529-8019.2012.01445.x (March/April 2012).
  • Wolverton SE: Comprehensive Dermatologic Drug Therapy. 3rd edition. Elsevier, Philadelphia, 2013 (in press).
  • Lebwohl MG, Heymann WR, Berth-Jones J, Coulson I: Treatment of Skin Disease. 4th edition, Elsevier, Philadelphia, 2013 (in press).


Tuesday, March 05
9:00 AMIntroduction / Dr. Callen
9:05 AMAntimalarial agents / Dr. Rosenbach
9:25 AMTumor necrosis antagonists – are they really safe for long term use? / Dr. Lebwohl
9:45 AMRituximab / Dr. Zone
10:05 AMAntibiotic safety in patients with Acne / Dr. Margolis
10:25 AMIsotretinoin / Dr. Owen
10:45 AMMethotrexate / Dr. Hughey
11:05 AMNewer anti-psoriatic agents / Dr. Van de Kerkhof
11:25 AMVismodegib / Dr. Bickers
11:45 AMPanel discussion – Q&A / All faculty